Form 8-K AMAG PHARMACEUTICALS For: May 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Wall St futures tick higher as oil retreats ahead of inflation data
- Oil falls on weaker demand outlook and higher US stocks
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
AMAG Pharma (AMAG) Tops Q1 EPS by 29c; Boosts FY15 Revenue Outlook
May 5, 2015 7:12 AM EDTAMAG Pharma (NASDAQ: AMAG) reported Q1 EPS of $1.17, $0.29 better than the analyst estimate of $0.88. Revenue for the quarter came in at $89.5 million versus the consensus estimate of $84.66 million.
AMAG Pharma sees FY2015 revenue of $395-430 million, versus prior guidance of $380-420 million and the... More
